Zinc supplements for HIV patients with low CD4 counts
Part of Immune system & allergy, Infections clinical trials.
This trial tests whether taking zinc supplements helps HIV patients who have low CD4 cell counts even when their virus is well-controlled. If your zinc levels are normal but your immune cells are slow to recover, this might be for you.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have confirmed HIV infection.
- You must be 18 years old or older.
- Your blood zinc level must be less than 150 micrograms per deciliter.
- You must be on a stable HIV medication regimen for at least 3 months and have taken it for at least 6 months total.
- Your HIV viral load must be undetectable (under 50 copies per mL), though brief minor rises are okay.
- Your CD4 count must be consistently below 500 cells per cubic millimeter, or have increased by less than 80 cells after a year of undetectable virus.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a medicine called IL-7 (interleukin-7) that may help raise the number of CD4 cells (a type of immune cell) in people with HIV whose CD4 counts stay low despite effective HIV treatment. The goal is to see if it can improve immune function and potentially reduce infection risk.
This study tests if alendronate, a bone-strengthening medicine, can shrink the reservoir of HIV that stays in your body even when on treatment. You must have well-controlled HIV on antiretroviral therapy for at least one year but no more than ten years, and meet specific health requirements.
This trial tests whether adding a traditional Chinese herbal medicine (Qiling Yiqi tablets) to standard HIV treatment can help raise CD4+ T-cell counts in people whose immune systems haven't fully recovered. It may offer a new option for those with persistently low counts despite effective viral suppression.
This study tests whether giving zinc supplements to older patients (65+) in the hospital can help prevent infections. It is for patients at Herlev Hospital who are not already taking high doses of zinc or receiving certain specialized treatments.
This study tests whether taking zinc can improve how your body controls blood sugar in people with prediabetes. It may help slow the progression toward type 2 diabetes, but you would need to meet specific health and medication criteria.
This study tests whether giving zinc supplements to very young babies (under 2 months) with severe infections helps them recover better. It takes place in Tanzania and involves adding zinc to their regular care.
Hear when a new HIV trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.